The Bubonic Plague bacterium is commonly transmitted from rodent to human by the oriental rat flea, Xenopsylla cheopis (Figure 1). The flea is a rodent parasite and human infection is accidental.
From 11000 to 24000 unencapsulated bacteria are regurgitated from the flea's midgut. Because of its low body temperature, the bacillus is unable to develop a capsule within the flea. The body temperature of the flea is approximately 27°C, whereas the human body temperature is 37°C - a more desirable environment. The plague is caused by Yersinia pestis, a Gram-negative bacillus, belonging to the family Enterobacteriaceae. Y. pestis is a non-spore-forming, facultative anaerobe. They are the only species of Yersinia that are non-motile at room temperature. In addition, Y. pestis is catalase-positive, oxidase-negative, urease-negative, and indole-negative (Figure 2).
Virulence and Pathogenicity: The virulence factors of Y. pestis are encoded by bacterial plasmids (pCD1), rather than by the bacterial DNA. It also hosts two other plasmid which are not carried by other Yersinia species, namely: pPCP1 and pMT1. pMT1 codes for phospholipase D: this is important for the ability of Y. pestis to be transmitted by fleas. pPCP1 codes for a protease, PIa, which activates plasminogen in human hosts and is an important virulence factor for pneumonic plague. pPCP1 and pMT1 along with a pathogenicity island called HPI, encode several proteins for Y. pestis pathogenesis. These virulence factors are required for bacterial adhesion and injection of proteins into the host cell, injection of bacteria into the host cell, and acquisition and binding of iron harvested from red blood cells.
The unencapsulated bacilli are phagocytosed. Those that are phagocytosed by neutrophils are killed, but those phagocytosed by macrophages are protected from destruction. The protected bacilli multiply within macrophages. The main goal of this bacteria is to block the macrophages ability to produce pro-inflammatory cytokines (like TNFα). After three to five hours at 37°C, the bacilli produce the F-1 capsular protein (See Vaccination) . The anti-phagocytotic capsule prevents further phagocytosis. Bacteria then spread to regional lymph nodes. Here they continue to rapidly multiply, causing swelling.
Virulence factors, transcribed from the bacteria plasmids, are translocated to the host cells. These include the V protein and YOPs (Yersinia outer proteins). In fact, Y. pestis has several virulence factors: attachment to host cells occurs via YadA “adhesin”; YadA also inhibits Complement activation. YopJ inhibits macrophage activation and pro-inflammatory cytokine production. YopH inhibits disrupts cytoskeleton and so inhibits phagocytosis (Figure 3). Once infected, cell death soon follows. Bacteria spread to regional lymph nodes. The swollen node is called a bubo, hence the term bubonic plague. Progressive infection spreads to nearly every organ of the body. Without antibiotic treatment, death may result within two to six days.
(1) Pneumonic plaque is the least common but most dangerous form of Y. pestis. The primary complication is due to inhalation of infectious respiratory droplets expelled from a human or animal that has plague pneumonia. However, it develops more typically due to a secondary complication of septicemic plague. It’s characterized by an infection of the lungs. Signs of pneumonic plague include:
2) Septicemic plague occurs when Y. pestis invades and continues to multiply in the bloodstream; it can develop without detectable lymph node swelling and pain. Patients who do not receive adequate treatment within 18 hours after onset of respiratory symptoms are unlikely to survive. It’s characterized by an infection in the bloodstream. Signs of septicemic plague include:
3) As discussed earlier, the
Bubonic plague is the most common disease caused
by Y. pestis. Signs of bubonic plague
are seen within two to six days of being bitten
by an infected
(1) Flea bite
(1) Eliminating food and shelter for rodents in
and near homes
Vaccination: The Fraction 1 (F-1) capsular antigen is the most immunogenic fraction in a Y. pestis bacilli preparation. Thus, a surface antigen is an excellent plague vaccine strategy. Early F-1 vaccine preparations induced antibodies and conferred protection. But while initial inoculations gave minimal side effects, booster inoculations produced sever hypersensitivity reactions (allergic reactions). This may have been due to other cell contaminants within the vaccine preparation. Therefore, the early F-1 vaccine, difficult and expensive to prepare, was discontinued.
A new vaccine preparation, consisting of genetically engineered F-1 and V proteins, is now under development. It promises to be the most effective to date, producing minimal side-effects.
Pier, G.B., Lyczak, J.B., & Wetzler, L.M. (2004). Immunology, Infection, and Immunity. Washington: ASM Press.